Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #awareness #biosimilars #education #gbma #webinar
- In May, GBMA Education, the educational arm of Australia’s Generic and Biosimilar Medicines Association (GBMA), hosted its second Biosimilar Awareness Week, which included online activities and the dissemination of online information to over 540,000 Australians on biosimilars and their crucial role “in the future of a sustainable healthcare system”
- As an additional segment of the Biosimilar Education Program for 2020, GBMA Education will launch a new CPD-accredited on-demand webinar series, and Marnie Peterson, GBMA Education CEO, said “a range of new educational resources for biosimilar medicines are currently in development and will be made available later in the year”
- With the collective efforts of the healthcare industry, the uptake of biosimilar medicines in Australia has grown from approximately 15.4% market share in 2018 to 23.9% in January 2020
THE DETAILS
CANBERRA, Australia — GBMA Education, the educational arm of Australia’s Generic and Biosimilar Medicines Association (GBMA), hosted its second Biosimilar Awareness Week on May 25-29 2020.
The Hon Greg Hunt, Federal Health Minister, acknowledged the Week’s success.
With a digital presence, Biosimilar Awareness Week disseminated online information to over 540,000 Australians on biosimilars and their crucial role “in the future of a sustainable healthcare system”.
Activities took place online, and the public and healthcare community engaged with a social media campaign led by @BiosimilarsAu across Facebook, LinkedIn and Twitter.
A variety of healthcare professionals and stakeholder organizations from the across the medicines industry contributed to the event, including Creaky Joints Australia, Crohn’s and Colitis Australia, NPS MedicineWise, the Pharmaceutical Society of Australia (PSA), the Society of Hospital Pharmacists of Australia (SHPA) and the Royal Australian College of GPs (RACGP), among others.
The Biosimilar Awareness Week is a segment of the larger Biosimilar Education Program supported by the Australian Government. The government presented GBMA Education with the Biosimilar Educational Grant in April 2018.
With the collective efforts of the healthcare industry, the uptake of biosimilar medicines has grown from approximately 15.4% market share in 2018 to 23.9% in January 2020.
“Biosimilar medicines are becoming increasingly available in Australia. That’s why educational initiatives like Biosimilar Awareness Week are so important – as greater understanding and use of biosimilar medicines can help support the sustainability of the Australian healthcare system”, said Marnie Peterson, GBMA Education CEO.
“…a range of new educational resources for biosimilar medicines are currently in development and will be made available later in the year. In addition, the International Generic and Biosimilar Medicines Association (IGBA) is looking to support a ‘Global Biosimilars Week’ expected to run later in 2020”.
As an additional offering of the Biosimilar Education Program for 2020, GBMA Education will launch a new CPD-accredited on-demand webinar series, with GPs, specialists and pharmacists invited to present their views, insights and experiences around the use of biosimilar medicines.
The series panelists include:
- Prof Geoff McColl, Rheumatologist and Executive Dean of the Faculty of Medicine, University of Queensland
- Prof Michelle Leech, Rheumatologist and Deputy Dean of Medicine, Nursing and Health Science Office, Monash University
- Prof Steven Boyages, Endocrinologist and Clinical Professor, Medicine at Westmead Clinical School
- Dr Harry Nespolon, General Practitioner and President, RACGP
- A/Prof Michael Ward, Hospital Pharmacist and Discipline Leader: Pharmacy education, University of South Australia Clinical and Health Sciences
- Dr Shane Jackson, Community Pharmacist and Policy Advisor, PSA
- Anthony Tassone, Community Pharmacist and President, Pharmacy Guild of Australia (Victoria)
- David Ford, Hospital Pharmacist and Executive Director of Pharmacy and Redevelopment, North East Health Wangaratta
- Catherine Bronger, Community Pharmacist and National Councillor of the Pharmacy Guild of Australia
Learn more about Pricentric ONE and our Global Pricing Solutions!
Contact us with your questions and global pricing needs, and an expert will follow up shortly.